KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $25,631,000 | +46.9% | 142,546 | -15.3% | 0.08% | +36.1% |
| Q2 2017 | $17,442,000 | +318.3% | 168,246 | +216.6% | 0.06% | +221.1% |
| Q1 2017 | $4,170,000 | +1450.2% | 53,136 | +785.6% | 0.02% | +1800.0% |
| Q4 2016 | $269,000 | -96.7% | 6,000 | -95.9% | 0.00% | -97.4% |
| Q3 2016 | $8,115,000 | +680.3% | 145,265 | +598.4% | 0.04% | +680.0% |
| Q2 2016 | $1,040,000 | -14.5% | 20,800 | -21.5% | 0.01% | -28.6% |
| Q1 2016 | $1,216,000 | -7.6% | 26,481 | +24.0% | 0.01% | -12.5% |
| Q4 2015 | $1,316,000 | +148.8% | 21,350 | +124.6% | 0.01% | +166.7% |
| Q3 2015 | $529,000 | -78.3% | 9,507 | -76.2% | 0.00% | -81.2% |
| Q2 2015 | $2,435,000 | +208.2% | 39,950 | +191.5% | 0.02% | +166.7% |
| Q1 2015 | $790,000 | -21.5% | 13,703 | -61.2% | 0.01% | -40.0% |
| Q3 2014 | $1,007,000 | – | 35,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |